CA
CGN Advisors’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $400K | Buy |
2,157
+112
| +5% | +$20.8K | 0.04% | 232 |
|
2025
Q1 | $428K | Buy |
2,045
+191
| +10% | +$40K | 0.04% | 225 |
|
2024
Q4 | $329K | Hold |
1,854
| – | – | 0.03% | 245 |
|
2024
Q3 | $366K | Buy |
1,854
+112
| +6% | +$22.1K | 0.04% | 228 |
|
2024
Q2 | $299K | Sell |
1,742
-59
| -3% | -$10.1K | 0.03% | 229 |
|
2024
Q1 | $328K | Sell |
1,801
-510
| -22% | -$92.9K | 0.04% | 212 |
|
2023
Q4 | $358K | Sell |
2,311
-2,874
| -55% | -$445K | 0.05% | 198 |
|
2023
Q3 | $773K | Buy |
5,185
+902
| +21% | +$134K | 0.1% | 160 |
|
2023
Q2 | $577K | Buy |
4,283
+94
| +2% | +$12.7K | 0.08% | 166 |
|
2023
Q1 | $668K | Buy |
4,189
+446
| +12% | +$71.1K | 0.11% | 155 |
|
2022
Q4 | $605K | Sell |
3,743
-50
| -1% | -$8.08K | 0.11% | 158 |
|
2022
Q3 | $509K | Buy |
3,793
+202
| +6% | +$27.1K | 0.13% | 163 |
|
2022
Q2 | $550K | Hold |
3,591
| – | – | 0.16% | 143 |
|
2022
Q1 | $582K | Sell |
3,591
-728
| -17% | -$118K | 0.15% | 136 |
|
2021
Q4 | $585K | Buy |
4,319
+2,436
| +129% | +$330K | 0.15% | 133 |
|
2021
Q3 | $203K | Hold |
1,883
| – | – | 0.07% | 195 |
|
2021
Q2 | $212K | Hold |
1,883
| – | – | 0.07% | 206 |
|
2021
Q1 | $204K | Sell |
1,883
-11
| -0.6% | -$1.19K | 0.07% | 193 |
|
2020
Q4 | $203K | Buy |
+1,894
| New | +$203K | 0.08% | 189 |
|